| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |